Closed-loop insulin delivery system enhances type 1 diabetes glycemic control.
Accepted version
Peer-reviewed
Repository URI
Repository DOI
Change log
Authors
Fuchs, Julia
Hovorka, Roman https://orcid.org/0000-0003-2901-461X
Abstract
Brown SA, Kovatchev BP, Raghinaru D, Lum JW, Buckingham BA, Kudva YC, et al. Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes. N Engl J Med 2019;381:1707-17.
Question Among patients with type 1 diabetes, what is the therapeutic efficacy of a closed-loop system (that detects glucose and administers insulin), compared with a sensor-augmented system (that requires user input), in keeping glucose levels within 70 to 180 mg per deciliter?
Description
Keywords
Blood Glucose, Diabetes Mellitus, Type 1, Humans, Hypoglycemic Agents, Insulin, Insulin Infusion Systems, Pancreas, Artificial
Journal Title
J Pediatr
Conference Name
Journal ISSN
0022-3476
1097-6833
1097-6833
Volume Title
218
Publisher
Elsevier BV
Publisher DOI
Sponsorship
Cambridge University Hospitals NHS Foundation Trust (CUH) (146281)
National Institute of Diabetes and Digestive and Kidney Diseases (R01DK085621)
National Institute of Diabetes and Digestive and Kidney Diseases (DP3DK112176)
National Institute of Diabetes and Digestive and Kidney Diseases (R01DK085621)
National Institute of Diabetes and Digestive and Kidney Diseases (DP3DK112176)